je.st
news
Tag: pharma
Moberg Pharma Announces Issue of U.S. Patent for Kerasal Nail
2015-03-25 09:30:01| Appliances - Topix.net
Moberg Pharma AB today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,987,330 for Moberg Pharma's market-leading product Kerasal NailA , an over-the-counter product for fungal nails.
Tags: issue
patent
announces
nail
Genedata Partners with Bayer Pharma AG on Innovative Workflow Platform for High-Throughput Cell Line Development
2015-03-23 11:31:17| Industrial Newsroom - All News for Today
Novel Cell Line Development (CLD) data platform to support the generation and assessment of mammalian production cell lines Basel, Switzerland - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a collaboration with Bayer Pharma AG to develop a...
Tags: line
development
cell
partners
Sun Pharma surpasses SBI in market valuation
2015-03-17 10:56:07| Chemicals - Topix.net
Drug major Sun Pharmaceutical Industries on Tuesday surpassed SBI, country's largest public sector lender, in terms of market valuation. Sun Pharma's market capitalisation increased to Rs 2,15,394.82 crore, following over one per cent rally in the stock at the BSE, overtaking SBI whose valuation stood at Rs 2,09,488.41 crore during the afternoon trade.
Tags: market
sun
valuation
pharma
Valeant boosts offer for Salix Pharma to about $11.11B
2015-03-16 14:06:50| Biotech - Topix.net
Valeant is raising its offer for Salix Pharmaceuticals to about $11.11 billion, heating up a bidding fight for the company. The Canadian drug maker's new bid is for $173 per Salix share, a 2 percent premium over Friday closing price of $169.40.
Tags: offer
pharma
boosts
salix
Endo Intl has offered to buy Salix Pharma -source
2015-03-11 20:18:02| Biotech - Topix.net
Endo International Plc has made an offer to buy Salix Pharmaceuticals Ltd for more than $10 billion, trumping Canada's Valeant Pharmaceuticals International Inc's offer, a person familiar with the matter said. Valeant agreed to buy the bowel drug maker in late February for about $10 billion, or $158 all cash offer per share.
Sites : [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] next »